4//SEC Filing
Nabulsi Azmi 4
Accession 0001209191-22-048471
CIK 0001783183other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:05 PM ET
Size
6.8 KB
Accession
0001209191-22-048471
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Award
Common Stock
2022-09-01+7,500→ 41,971 total
Holdings
- 2,355.22(indirect: By 401(k))
Common Stock
- 785,700(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") granted on September 1, 2022. Fifty percent (50%) of the total number of RSUs granted vest on each of March 1, 2023 and June 1, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]Includes 1,093 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2022.
- [F3]Includes 1,511.80 shares acquired under the Phathom Pharmaceuticals, Inc. 401(k) plan.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001791412
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:05 PM ET
- Size
- 6.8 KB